Início › Carcinoma urotelial (células de transição) › Califórnia › Los Angeles
Ensaios clínicos de Carcinoma urotelial (células de transição) em Los Angeles, CA
17 estudos para Carcinoma urotelial (células de transição) estão buscando participantes em locais em Los Angeles e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecrutandoFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecrutandoFase 1/2
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- e mais 1
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecrutandoFase 1/2
- University of Southern California, Los Angeles
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecrutandoFase 3
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
RecrutandoFase 2/3
- Research Site, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecrutandoFase 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecrutandoFase 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RecrutandoFase 2/3
- Research Site, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecrutandoFase 1/2
- Los Angeles Cancer Network, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecrutandoFase 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecrutandoFase 2
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- e mais 6
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Recrutando
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RecrutandoFase 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecrutandoFase 1/2
- University of Southern California, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
RecrutandoFase 1
- University of Southern California, Los Angeles
Ensaios de Carcinoma urotelial (células de transição) em outras cidades
- Nashville, TN23 estudos
- New York City, NY22 estudos
- Houston, TX19 estudos
- Dallas, TX18 estudos
- Edison, NJ18 estudos
- Queens, NY15 estudos
- Chicago, IL14 estudos
- Arlington, VA12 estudos
- Boston, MA11 estudos
- San Antonio, TX11 estudos
- Austin, TX10 estudos
- Orange, CA10 estudos
Outros estudos em Los Angeles
- Câncer de Pulmão de Não Pequenas Células87 estudos
- Câncer (todos os tipos)74 estudos
- Câncer de Mama73 estudos
- Câncer de Próstata61 estudos
- Câncer Colorretal59 estudos
- Câncer Metastático57 estudos
- Câncer de Ovário50 estudos
- Câncer de Pulmão45 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço42 estudos
- Câncer de Pâncreas35 estudos
- Câncer Endometrial34 estudos
- Melanoma34 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.